Shapiro RS - Search Results

1

Unearthing the story of the first antifungal drugs.

Shapiro RS. Shapiro RS. Nat Rev Microbiol. 2023 Oct;21(10):631. doi: 10.1038/s41579-023-00937-8. Nat Rev Microbiol. 2023. PMID: 37700051 No abstract available.

2

Regulatory circuitry governing fungal development, drug resistance, and disease.

Shapiro RS, Robbins N, Cowen LE. Shapiro RS, et al. Microbiol Mol Biol Rev. 2011 Jun;75(2):213-67. doi: 10.1128/MMBR.00045-10. Microbiol Mol Biol Rev. 2011. PMID: 21646428 Free PMC article. Review.

3

New pathogens, new tricks: emerging, drug-resistant fungal pathogens and future prospects for antifungal therapeutics.

Geddes-McAlister J, Shapiro RS. Geddes-McAlister J, et al. Among authors: shapiro rs. Ann N Y Acad Sci. 2019 Jan;1435(1):57-78. doi: 10.1111/nyas.13739. Epub 2018 May 15. Ann N Y Acad Sci. 2019. PMID: 29762860 Review.

4

Targeting fungal membrane homeostasis with imidazopyrazoindoles impairs azole resistance and biofilm formation.

Revie NM, Iyer KR, Maxson ME, Zhang J, Yan S, Fernandes CM, Meyer KJ, Chen X, Skulska I, Fogal M, Sanchez H, Hossain S, Li S, Yashiroda Y, Hirano H, Yoshida M, Osada H, Boone C, Shapiro RS, Andes DR, Wright GD, Nodwell JR, Del Poeta M, Burke MD, Whitesell L, Robbins N, Cowen LE. Revie NM, et al. Among authors: shapiro rs. Nat Commun. 2022 Jun 25;13(1):3634. doi: 10.1038/s41467-022-31308-1. Nat Commun. 2022. PMID: 35752611 Free PMC article.

5

Antimicrobial Susceptibility Testing for Three Malassezia Species.

Rathie B, Theelen B, Laurence M, Shapiro RS. Rathie B, et al. Among authors: shapiro rs. Microbiol Spectr. 2023 Aug 17;11(4):e0507622. doi: 10.1128/spectrum.05076-22. Epub 2023 Jun 13. Microbiol Spectr. 2023. PMID: 37310217 Free PMC article.

6

Powering up antifungal treatment: using small molecules to unlock the potential of existing therapies.

Shapiro RS, Gerstein AC. Shapiro RS, et al. mBio. 2023 Aug 31;14(4):e0107323. doi: 10.1128/mbio.01073-23. Epub 2023 Aug 2. mBio. 2023. PMID: 37530533 Free PMC article.

7

The Hsp90 co-chaperone Sgt1 governs Candida albicans morphogenesis and drug resistance.

Shapiro RS, Zaas AK, Betancourt-Quiroz M, Perfect JR, Cowen LE. Shapiro RS, et al. PLoS One. 2012;7(9):e44734. doi: 10.1371/journal.pone.0044734. Epub 2012 Sep 6. PLoS One. 2012. PMID: 22970302 Free PMC article.

8

CRISPR-based genomic tools for the manipulation of genetically intractable microorganisms.

Shapiro RS, Chavez A, Collins JJ. Shapiro RS, et al. Nat Rev Microbiol. 2018 Jun;16(6):333-339. doi: 10.1038/s41579-018-0002-7. Nat Rev Microbiol. 2018. PMID: 29599458 Review.

9

Genetic interaction analysis in microbial pathogens: unravelling networks of pathogenesis, antimicrobial susceptibility and host interactions.

Halder V, McDonnell B, Uthayakumar D, Usher J, Shapiro RS. Halder V, et al. Among authors: shapiro rs. FEMS Microbiol Rev. 2021 May 5;45(3):fuaa055. doi: 10.1093/femsre/fuaa055. FEMS Microbiol Rev. 2021. PMID: 33145589 Review.

10

The SAGA and NuA4 component Tra1 regulates Candida albicans drug resistance and pathogenesis.

Razzaq I, Berg MD, Jiang Y, Genereaux J, Uthayakumar D, Kim GH, Agyare-Tabbi M, Halder V, Brandl CJ, Lajoie P, Shapiro RS. Razzaq I, et al. Among authors: shapiro rs. Genetics. 2021 Oct 2;219(2):iyab131. doi: 10.1093/genetics/iyab131. Genetics. 2021. PMID: 34849885 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

242 results

Search Page